AOP-Wiki

API

All KERs

Showing 2401 to 2425 of 3102 KERs

ID	Upstream Event	Downstream Event	Creation Date	Last Updated	AOPs

1026	1002: Inhibition, Deiodinase 2	1003: Decreased, Triiodothyronine (T3)	Nov 29, 2016	Nov 19, 2025	2 AOPs 155: Deiodinase 2 inhibition leading to increased mortality via reduced posterior swim bladder inflation 156: Deiodinase 2 inhibition leading to increased mortality via reduced anterior swim bladder inflation
1042	1002: Inhibition, Deiodinase 2	1004: Reduced, Posterior swim bladder inflation	Nov 29, 2016	Oct 7, 2022	1 AOP 155: Deiodinase 2 inhibition leading to increased mortality via reduced posterior swim bladder inflation
1043	1002: Inhibition, Deiodinase 2	1007: Reduced, Anterior swim bladder inflation	Nov 29, 2016	Mar 8, 2019	None
1199	1002: Inhibition, Deiodinase 2	1116: Decreased, Triiodothyronine (T3) in tissues	Nov 29, 2016	Nov 19, 2025	1 AOP 190: Type II iodothyronine deiodinase (DIO2) inhibition leading to altered amphibian metamorphosis
3653	1002: Inhibition, Deiodinase 2	2093: Decreased brain T4/T3	Oct 8, 2025	Oct 8, 2025	1 AOP 610: Decreased thyroid hormone levels in the brain regulated via transport, metabolism and TR activation leading to decreased cognition and motor function
1200	1153: Inhibition, Deiodinase 3	1154: Increased, Triiodothyronine (T3) in tissues	Nov 29, 2016	Nov 19, 2025	1 AOP 191: Type III iodotyrosine deiodinase (DIO3) inhibition leading to altered amphibian metamorphosis
1203	1156: Inhibition, Dual oxidase	277: TH synthesis, Decreased	Nov 29, 2016	Dec 3, 2016	1 AOP 193: Dual oxidase (DUOX) inhibition leading to altered amphibian metamorphosis
3121	2207: inhibition, EKR1/2 signaling pathway	2208: Aberrant, synaptic formation and plasticity	Jan 25, 2024	Jan 25, 2024	1 AOP 522: Estrogen antagonism leading to increased risk of autism-like behavior
597	593: Inhibition, Ether-a-go-go (ERG) voltage-gated potassium channel	585: Decreased, Sodium conductance 1	Nov 29, 2016	Dec 3, 2016	1 AOP 95: Ether-a-go-go (ERG) voltage-gated potassium channel inhibition leading to reduced survival
3419	593: Inhibition, Ether-a-go-go (ERG) voltage-gated potassium channel	1961: Prolongation of Action Potential	Nov 21, 2024	Nov 21, 2024	1 AOP 555: Inhibition, Ether-a-go-go (ERG) Voltage-Gated Potassium Channel leading to heart failure
1692	1490: Inhibition of fatty acid beta oxidation	1305: Increase, cytosolic fatty acid	Nov 13, 2017	Nov 13, 2017	1 AOP 213: Inhibition of fatty acid beta oxidation leading to nonalcoholic steatohepatitis (NASH)
1056	1016: Inhibition, Feeding	351: Increased Mortality	Nov 29, 2016	Dec 3, 2016	2 AOPs 160: Ionotropic gamma-aminobutyric acid receptor activation mediated neurotransmission inhibition leading to mortality 161: Glutamate-gated chloride channel activation leading to neurotransmission inhibition associated mortality
3087	1016: Inhibition, Feeding	350: Increase, Mortality	Oct 17, 2023	Oct 17, 2023	1 AOP 471: Neuron defect induced early behavioral change
2080	1761: Inhibition, Fin regeneration	1005: Reduced, Swimming performance	Apr 21, 2020	Jul 10, 2020	1 AOP 334: Glucocorticoid Receptor Agonism Leading to Impaired Fin Regeneration
519	471: Inhibition, FoxA2	472: Down Regulation, CPT1A	Nov 29, 2016	Dec 3, 2016	1 AOP 60: NR1I2 (Pregnane X Receptor, PXR) activation leading to hepatic steatosis
523	471: Inhibition, FoxA2	474: Down Regulation, HMGCS2	Nov 29, 2016	Dec 3, 2016	1 AOP 60: NR1I2 (Pregnane X Receptor, PXR) activation leading to hepatic steatosis
804	804: Inhibition, HMG-CoA reductase	805: Decreased, mevalonate	Nov 29, 2016	Dec 3, 2016	1 AOP 124: HMG-CoA reductase inhibition leading to decreased fertility
1827	1574: Inhibition, IKK complex	202: Inhibition, Nuclear factor kappa B (NF-kB)	Jan 7, 2019	Mar 7, 2019	1 AOP 278: IKK complex inhibition leading to liver injury
159	147: Inhibition, Inducible Nitric Oxide Synthase by Metabolite CGA 265307	270: Induction, Sustained Hepatotoxicity	Nov 29, 2016	Dec 3, 2016	1 AOP 32: Inhibition of iNOS, hepatotoxicity, and regenerative proliferation leading to liver tumors
1197	1152: Inhibition, Iodotyrosine deiodinase (IYD)	425: Thyroidal Iodide, Decreased	Nov 29, 2016	Dec 3, 2016	1 AOP 188: Iodotyrosine deiodinase (IYD) inhibition leading to altered amphibian metamorphosis
2476	1152: Inhibition, Iodotyrosine deiodinase (IYD)	281: T4 in serum, Decreased	Sep 9, 2021	Sep 9, 2021	1 AOP 188: Iodotyrosine deiodinase (IYD) inhibition leading to altered amphibian metamorphosis
3587	2348: Inhibition, Liver regeneration	2019: Non-alcoholic fatty liver disease	Aug 16, 2025	Aug 16, 2025	1 AOP 591: DBDPE-induced DNA damage increase in liver leading to Non-alcoholic fatty liver disease via liver steatosis and inhibition of regeneration
1413	1307: Inhibition, LXR	468: Inhibition, PPAR alpha	Apr 12, 2017	Apr 12, 2017	None
1781	1542: Inhibition, Mitochondrial complex III	1545: Decrease in mitochondrial oxidative phosphorylation	Dec 19, 2018	Mar 7, 2019	1 AOP 273: Mitochondrial complex inhibition leading to liver injury
1872	1542: Inhibition, Mitochondrial complex III	1477: OXPHOS, decreased	Mar 19, 2019	Mar 19, 2019	None

Key Event Relationships (KERs)

All KERs